Alpha Cubed Investments LLC Acquires 1,205 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Alpha Cubed Investments LLC lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.9% during the 4th quarter, HoldingsChannel.com reports. The firm owned 63,663 shares of the healthcare conglomerate’s stock after buying an additional 1,205 shares during the quarter. UnitedHealth Group accounts for about 1.9% of Alpha Cubed Investments LLC’s holdings, making the stock its 16th biggest position. Alpha Cubed Investments LLC’s holdings in UnitedHealth Group were worth $33,517,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. MONECO Advisors LLC boosted its holdings in UnitedHealth Group by 128.0% in the fourth quarter. MONECO Advisors LLC now owns 8,687 shares of the healthcare conglomerate’s stock valued at $4,573,000 after acquiring an additional 4,877 shares during the last quarter. Brighton Jones LLC boosted its holdings in UnitedHealth Group by 15.1% in the fourth quarter. Brighton Jones LLC now owns 18,004 shares of the healthcare conglomerate’s stock valued at $9,478,000 after acquiring an additional 2,365 shares during the last quarter. Vanguard Capital Wealth Advisors boosted its holdings in UnitedHealth Group by 0.4% in the fourth quarter. Vanguard Capital Wealth Advisors now owns 13,722 shares of the healthcare conglomerate’s stock valued at $7,224,000 after acquiring an additional 48 shares during the last quarter. Compass Capital Management Inc. acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $273,000. Finally, Auxano Advisors LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $239,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Price Performance

Shares of NYSE:UNH traded down $5.33 on Tuesday, hitting $483.70. The company’s stock had a trading volume of 3,366,904 shares, compared to its average volume of 4,466,545. The company has a 50-day simple moving average of $485.19 and a 200 day simple moving average of $513.81. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70. The company has a market capitalization of $445.04 billion, a PE ratio of 29.63, a PEG ratio of 1.43 and a beta of 0.54. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company’s revenue was up 8.6% compared to the same quarter last year. During the same quarter last year, the firm posted $6.26 EPS. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.55%. UnitedHealth Group’s dividend payout ratio is 45.97%.

Insider Buying and Selling

In related news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the SEC, which is available through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the company. Piper Sandler boosted their price target on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Truist Financial reaffirmed a “buy” rating and set a $600.00 target price on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Oppenheimer reaffirmed an “outperform” rating and set a $610.00 target price on shares of UnitedHealth Group in a research report on Wednesday, January 17th. HSBC raised UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price target for the company in a research report on Thursday, April 4th. Finally, StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, April 18th. Four research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $570.05.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.